RCS-21
/ RNATICS
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 21, 2025
AMIR-21: Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: RNATICS GmbH | N=48 ➔ 24 | Trial completion date: Mar 2026 ➔ Aug 2026 | Trial primary completion date: Jan 2026 ➔ Jun 2026
Enrollment change • Trial completion date • Trial primary completion date
March 11, 2025
AMIR-21: Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: RNATICS GmbH | Not yet recruiting ➔ Recruiting
Enrollment open
1 to 2
Of
2
Go to page
1